Karyopharm Therapeutics | 销售

Sales 更改 日
AbbVie USD 14.3B 374M 2023-12
Abbott USD 9.96B 281M 2024-03
Amgen USD 8.2B 1.29B 2023-12
AstraZeneca USD 12.02B 532M 2023-12
Bristol-Myers Squibb USD 11.48B 511M 2023-12
Eli Lilly USD 9.35B 145.2M 2023-12
GlaxoSmithKline GBP 8.05B 95M 2023-12
Incyte USD 1.01B 94.32M 2023-12
J&J USD 21.38B 15M 2024-03
MacroGenics USD 10.72M 323K 2023-12
Merck USD 14.63B 1.33B 2023-12
Novartis USD 11.83B 54M 2024-03
Novartis USD 11.78B 316M 2023-12
Pfizer USD 14.25B 1.02B 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Roche Holding CHF 28.94B 842M 2023-12
Takeda JPY 1.11T 68.1B 2023-12
TG Therapeutics USD 43.97M 121.84M 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Xencor USD 44.69M 14.48M 2023-12



Karyopharm Therapeutics 销售 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.